Home›Timolol›Timolol + Darunavir Ethanolate And Cobicistat

Does Timolol Interact with Darunavir Ethanolate And Cobicistat?

CDI records a unknown classification for Timolol and Darunavir Ethanolate And Cobicistat. The stored summary is: carvedilol, metoprolol, timolol ↑ beta-blockers Clinical monitoring is recommended for co-administration with beta-blockers that are metabolized by CYP2D6. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity: Unknown
Darunavir Ethanolate And Cobicistat Class: Cytochrome P450 3A Inhibitor
Management: Consult your pharmacist
Data Source: U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Timolol and your doctor is considering prescribing Darunavir Ethanolate And Cobicistat (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Never stop or change either medication without first consulting your healthcare provider

💊 Timolol(Timoptic)+💊 Darunavir Ethanolate And Cobicistat(Prezcobix)

Severity & Interaction Details

ℹ️

unknown

Interaction documented — severity unclassified

The CDI record includes an interaction but its severity has not been classified.

Severity scale

MinorContra

On record

Yes

Drug A class

—

Drug B class

Cytochrome P450 3A Inhibitor

Source

FDA drug label - darunavir ethanolate and cobicistat

What this means in plain English

carvedilol, metoprolol, timolol ↑ beta-blockers Clinical monitoring is recommended for co-administration with beta-blockers that are metabolized by CYP2D6.

About Timolol and Darunavir Ethanolate And Cobicistat

Darunavir Ethanolate And Cobicistat is a Cytochrome P450 3A Inhibitor. You may recognize them by the brand names Timoptic and Prezcobix.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: FDA drug label - darunavir ethanolate and cobicistat

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

PubMed

A Scoping Review of Clinical Trials on the Expanding Role of Beta‑Blockers in Dermatology.about Timolol · 2026-05

PubMed

Topical Timolol Beyond Infancy: A Retrospective Study of Its Use in Persistent Infantile Hemangiomas.about Timolol · 2026-05

PubMed

Co-Administration of MPC Polymer Enhances the Ocular Absorption and Intraocular Pressure-Lowering Effect of Timolol Maleate.about Timolol · 2026-05

PubMed

Prevalence and Severity of Potential Drug-Drug Interactions in People Living with HIV on Antiretroviral Therapy in the United States.about Darunavir Ethanolate And Cobicistat · 2026-11

PubMed

Therapeutic drug monitoring uncovering incorrect antiretroviral drug intake in a patient with swallowing difficulties.about Darunavir Ethanolate And Cobicistat · 2026-09

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Timolol and Darunavir Ethanolate And Cobicistat against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.